Filter posts

A Patient Advocate Perspective on BIO

As the mother of a 12-year-old son with hypophosphatasia, the BIO International Convention is much …

Taking on High-Risk Investments to Understand Brains and Solve Epilepsy

30 percent of people living with epilepsy do not have seizure control. Moreover, many can …

Life After Start-Up Stadium: ViRAZE

For the third year, the BIO International Convention will host the 2017 BIO Start-Up Stadium …

Life After Start-Up Stadium: Immunome

For the third year, the BIO International Convention will host the 2017 BIO Start-Up Stadium Empowering the …

IRS Issues Guidance on Start-up R&D Credit

At the end of March, the IRS issued interim guidance explaining how eligible small businesses …

Jim Greenwood Celebrates JOBS Act Turning Five (Op-Ed in The Hill)

Five years ago today, the Jumpstart Our Business Startups (JOBS) Act became law. The JOBS …

#BIO2017: A Peek at Partnering | Protalix Biotherapeutics' Bill Taylor

Breaking Buzz is BIO’s newest blog series that reaches across the globe to bring you …

BIO Officially Opens Registration for the 2017 World Congress on Industrial Biotechnology

We are  pleased to announce BIO’s World Congress on Industrial Biotechnology is the world’s largest …

Best Practices for Communication Between FDA and IND Sponsors During Drug Development

The FDA recently released an online course to provide insights to drug sponsors on communicating …

ICYMI: The Administration Proposes Last Minute Updates to the Regulation of GE Crops and Animals

Just a few days before President-elect Donald Trump takes office, the Obama administration released a series of proposals …